​
​

NLS Pharmaceutics Ownership | Who Owns NLS Pharmaceutics?

OverviewForecastFinancialsChart

NLS Pharmaceutics Ownership Summary

NLS Pharmaceutics is owned by 22.34% institutional investors, 28.29% insiders, and 49.38% retail investors. Ubs group is the largest institutional shareholder, holding 0.62% of NLSP shares. SFR Global Wealth Fund is the top mutual fund, with 2.62% of its assets in NLS Pharmaceutics shares.

NLSP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNLS Pharmaceutics22.34%28.29%49.38%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ubs group235.72K0.62%$51.15K
Citadel advisors136.27K0.36%$29.56K
Geode capital management14.36K0.04%$3.12K
Bank of america corp /de/90.000.00%$19.00
Jane street group---
Bvf inc/il---
Renaissance---
Xtx topco---
Hrt financial lp---
Armistice capital---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management14.36K-$3.12K
Renaissance---
Bvf inc/il---
Bank of america corp /de/90.00-$19.00
Jane street group---
Ubs group235.72K-$51.15K
Citadel advisors136.27K-$29.56K
Xtx topco---
Hrt financial lp---
Armistice capital---

Top Buyers

HolderShares% AssetsChange
Ubs group235.72K-235.72K
Citadel advisors136.27K-117.09K
Geode capital management14.36K--
Bank of america corp /de/90.00--
Hrt financial lp---16.83K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---5.75M
Armistice capital---2.31M
Jane street group---43.67K
Xtx topco---25.59K
Renaissance---21.78K

New Positions

HolderShares% AssetsChangeValue
Ubs group235.72K-235.72K$51.15K

Sold Out

HolderChange
Hrt financial lp-16.83K
Renaissance-21.78K
Xtx topco-25.59K
Jane street group-43.67K
Armistice capital-2.31M

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024928.57%8,526,8524.52%224.89%525.00%1-
Mar 31, 2024740.00%8,157,93239.91%219.16%4---100.00%
Dec 31, 20235-28.57%5,830,804-7.36%150.55%--100.00%1-50.00%
Sep 30, 20237-22.22%6,294,283-2.58%521.79%2-60.00%2100.00%
Jun 30, 2023928.57%6,461,2091.50%541.90%5-1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
SFR Global Wealth Fund100.00K2.62%97.50K
Fidelity Nasdaq Composite Index359.000.01%-

NLSP Ownership FAQ

Who Owns NLS Pharmaceutics?

NLS Pharmaceutics shareholders are primarily institutional investors at 22.34%, followed by 28.29% insiders and 49.37% retail investors. The average institutional ownership in NLS Pharmaceutics's industry, Biotech Stocks , is 44.70%, which NLS Pharmaceutics falls below.

Who owns the most shares of NLS Pharmaceutics?

NLS Pharmaceutics’s largest shareholders are Ubs group (235.72K shares, 0.62%), Citadel advisors (136.27K shares, 0.36%), and Geode capital management (14.36K shares, 0.04%). Together, they hold 1.01% of NLS Pharmaceutics’s total shares outstanding.

Does Blackrock own NLS Pharmaceutics?

BlackRock is not among the top 10 institutional shareholders of NLS Pharmaceutics.

Who is NLS Pharmaceutics’s biggest shareholder by percentage of total assets invested?

Geode capital management is NLS Pharmaceutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 14.36K NLS Pharmaceutics shares, valued at 3.12K$.

Who is the top mutual fund holder of NLS Pharmaceutics shares?

SFR Global Wealth Fund is the top mutual fund holder of NLS Pharmaceutics shares, with 2.62% of its total shares outstanding invested in 100K NLS Pharmaceutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools